Bioxytran Stock Net Income
| BIXT Stock | USD 0.09 0.01 12.92% |
Bioxytran's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Bioxytran OTC Stock price.
Bioxytran |
Bioxytran OTC Stock Net Income Analysis
Bioxytran's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Bioxytran Net Income | (4.04 M) |
Most of Bioxytran's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioxytran is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Bioxytran reported net income of (4.04 Million). This is 101.18% lower than that of the Biotechnology sector and 105.77% lower than that of the Health Care industry. The net income for all United States stocks is 100.71% higher than that of the company.
Bioxytran Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioxytran's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Bioxytran could also be used in its relative valuation, which is a method of valuing Bioxytran by comparing valuation metrics of similar companies.Bioxytran is currently under evaluation in net income category among its peers.
Bioxytran Fundamentals
| Return On Asset | -7.04 | |||
| Current Valuation | 19.06 M | |||
| Shares Outstanding | 144.64 M | |||
| Shares Owned By Insiders | 65.60 % | |||
| Price To Sales | 532.56 X | |||
| EBITDA | (3.59 M) | |||
| Net Income | (4.04 M) | |||
| Cash And Equivalents | 500.68 K | |||
| Total Debt | 2.17 M | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (839.44 K) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 2.71 | |||
| Beta | -0.43 | |||
| Market Capitalization | 17.21 M | |||
| Total Asset | 370.94 K | |||
| Retained Earnings | (11.22 M) | |||
| Working Capital | (3.37 M) | |||
| Z Score | -80.36 | |||
| Net Asset | 370.94 K |
About Bioxytran Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioxytran's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioxytran using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioxytran based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bioxytran OTC Stock Analysis
When running Bioxytran's price analysis, check to measure Bioxytran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioxytran is operating at the current time. Most of Bioxytran's value examination focuses on studying past and present price action to predict the probability of Bioxytran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioxytran's price. Additionally, you may evaluate how the addition of Bioxytran to your portfolios can decrease your overall portfolio volatility.